Literature DB >> 11225430

[Etiopathogenesis of prostatitis]].

W Hochreiter1, P Bader.   

Abstract

The first step in adopting a practical approach to the management of patients with prostatitis lies in the realization that the etiology of the symptoms often remains unclear and the traditional etiologically based classification system is part of the problem and not the solution. This problem was recognized in 1995 by the National Institutes of Health Consensus Conference on prostatitis. It was suggested that the classification of this disease be changed. The traditional categories "chronic nonbacterial prostatitis" and "prostatodynia" were replaced by the new category "chronic pelvic pain syndrome." The introduction of the term "syndrome" reflects two issues: despite lack of evidence for bacterial involvement based on conventional methods, nonbacterial prostatitis may indeed still be an infectious disease, and the etiology of the symptoms may be caused by a disorder not related to the prostate gland alone.

Entities:  

Mesh:

Year:  2001        PMID: 11225430     DOI: 10.1007/s001200050424

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  4 in total

1.  [Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic treatment - a randomized controlled study].

Authors:  S Marx; U Cimniak; R Beckert; F Schwerla; K L Resch
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

2.  [Chronic pelvic pain and its comorbidity].

Authors:  M E Beutel; W Weidner; E Brähler
Journal:  Urologe A       Date:  2004-03       Impact factor: 0.639

Review 3.  Diagnosing the prostatitis patient: the dilemma continues.

Authors:  Jeannette M Potts
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 2.862

4.  Long-term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to non bacterial prostatitis.

Authors:  Amir Moayednia; Saeid Haghdani; Saeid Khosrawi; Elham Yousefi; Babak Vahdatpour
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.